Sangon Biotech (revision 27)
Old revision·19:45, 1 May 2025·StubTagTeodor
| Sangon Biotech (Shanghai) Co., Ltd.Organisation | |
|---|---|
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| Legal name | Sangon Biotech (Shanghai) Co., Ltd. |
| Trading name | SGN |
| Other designations | SGN Biotech, Sangon Biotech (Shanghai) |
| Identity | |
| Founded | 2004 |
| Headquarters | Shanghai, China |
| Industry | Research-compound supply |
| Shop domain | Visit SGN |
| Products and documentation | |
| Product scope | peptides, SARMs, injectable oils and raw materials |
| Catalogue size | 350+ listings (self-reported) |
| Documentation | Batch certificate of analysis reported with orders |
| Independent reports | Submitted to this wiki by purchasers; see §Independent testing record |
| Organisation infobox · conventions | |
Sangon Biotech (Shanghai) Co., Ltd. (trading as SGN; sangonbio.com) is a life-science reagent and peptide supplier trading as SGN from Shanghai, China, incorporated in 2004, whose catalogue spans research peptides alongside a broader range of laboratory reagents.[1][2]
The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]Incorporated in 2004, the organisation has one of the longer histories among the entities covered here.[1] Its catalogue is notably broader than the research-peptide sector norm, extending into general laboratory reagents, oligonucleotides and molecular-biology consumables, and its name appears in technical contexts unrelated to the research-compound trade.[2]
That breadth is the strongest element of its notability case and also the source of a scope question editors have discussed: an organisation whose peptide business is one line among many is not primarily a peptide supplier, and an article that treats it as one distorts what it is.
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe conventional practice for the peptide lines, with a batch certificate reporting purity and appearance, and water on some lots.[5] Reagent-line reports describe documentation typical of the laboratory-supply trade — specification sheets and lot-specific certificates — which is a different documentary tradition from the research-compound sector and generally a more standardised one.
No certification claim has been independently corroborated here.[2][6]
Product range
[edit]| Class | Representative listings | Documentation reported |
|---|---|---|
| Research peptides | Incretin analogues, repair peptides | Certificate, purity; water sometimes |
| Laboratory reagents | Buffers, enzymes, molecular-biology kits | Specification sheet, lot certificate |
| Oligonucleotides | Synthesis to order | Certificate, sequence confirmation |
| SARMs and raw materials | Bulk | Certificate, purity |
The reagent and oligonucleotide lines place this organisation in a different category from most covered here. Its inclusion in this wiki's supplier articles reflects its peptide listings, not the whole of its business.[2]
Independent testing record
[edit]Submitted reports on SGN peptide material to July 2026 are moderate in number. Reported area percent figures have been high and consistent with accompanying certificates.[5]
See also
References
- ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b c d Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ a b Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
- ^ World Health Organization, Good Manufacturing Practices for Pharmaceutical Products: Main Principles, WHO Technical Report Series. The general framework against which a GMP claim is assessed.